CO5190713A1 - Derivados de triazol e imidazol - Google Patents

Derivados de triazol e imidazol

Info

Publication number
CO5190713A1
CO5190713A1 CO00054541A CO00054541A CO5190713A1 CO 5190713 A1 CO5190713 A1 CO 5190713A1 CO 00054541 A CO00054541 A CO 00054541A CO 00054541 A CO00054541 A CO 00054541A CO 5190713 A1 CO5190713 A1 CO 5190713A1
Authority
CO
Colombia
Prior art keywords
lower alkyl
alkyl
pyridin
hydrogen
phenyl
Prior art date
Application number
CO00054541A
Other languages
English (en)
Inventor
Alexander Alanine
Bernd Buttelmann
Georg Jaeschke
Emmanuel Pinard
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO5190713A1 publication Critical patent/CO5190713A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un compuesto de la fórmula<EMI FILE="00054541_1" ID="1" IMF=JPEG >en dondeR1-R4 significa, independientemente, hidrógeno, -CF3, -OCF3, OCHF2, -OCH2F, alquilo inferior, alcoxilo inferior, halógeno, hidroxilo, fenilo, bencilo, amino, nitro, pirrol-l-ilo, alquil-sulfonilo inferior, alquil-sulfanilo inferior, ciano o benciloxilo; oR2 y R3 pueden ser, conjuntamente, -O-(CH2)2-O-, -O-CH2-O-, -O-(CH2)2-, -(CH2)3- o -CH=CH-CH=CH-;X significa -N=, -N(R8)- o -CH=;Y significa -N=, =N-, N(R8)- o -CH=; en donde uno de X o Y ha de ser nitrógeno;R5 significa el grupo<EMI FILE="00054541_2" ID="2" IMF=JPEG >en dondeR6 y R7 significan, independientemente uno de otro, hidrógeno, alquilo inferior, -C(O)- alquilo inferior, hidroxi-alquilo inferior, alquenilo inferior, -C(O)CH2OH oR6 y R7 pueden ser, junto con el átomo de N, -(CH2)n-, -(CH2)2-O-(CH2)2-, -CH2-CH=CH-CH2,-CH2-CH[OC(O)CH3]-(CH2)2, -CH2-CH[NHC(O)CH3]-(CH2)2, -O-(CH2)3-, -CH2-CH(OCH3)-(CH2)2-,-CH2-CH(halógeno)-(CH2)2-, -(CH2)2-CH(O-fenilo)-(CH2)2-, -(CH2)2-N(CHO)-(CH2)2-, -(CH2)2-N(COCH3)-(CH2)2, -CH2-CH(OH)-(CH2)3, -(CH2)2-CH(OH)-(CH2)2- o -(CH2)2- -N(bencilo)-CH2)2-;n significa 3 a 5; yR8 significa hidrógeno, alquilo inferior, alquenilo inferior, alquinilo inferior, -(CH2)m-O-alquilo inferior, -(CH2)m-OH, -(CH2)m-CHF2, -(CH2)m-CH2F, -(CH2)m-C(O)-alquilo inferior, -(CH2)m-C(O)O-alquilo inferior, -(CH2)m-CH(OH)-alquilo inferior, -(CH2)m-CH(OH)-(CH2)m-OH, -(CH2)m-C6H5, cuyo anillo de fenilo está opcionalmente sustituido por alquilo inferior, alcoxilo inferior o hidroxilo,-(CH2)m-C(=CH2)-alquilo inferior, -(CH2)m-cicloalquilo, -(CH2)m-CN, -(CH2)m-piridin-4-ilo, -(CH2)m-piridin-3-ilo o -(CH2)m-piridin-2-ilo;m significa = 0 a 4;y a sus sales de adición de ácido farmacéuticamente aceptables.
CO00054541A 1999-07-21 2000-07-19 Derivados de triazol e imidazol CO5190713A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99114313 1999-07-21

Publications (1)

Publication Number Publication Date
CO5190713A1 true CO5190713A1 (es) 2002-08-29

Family

ID=8238635

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00054541A CO5190713A1 (es) 1999-07-21 2000-07-19 Derivados de triazol e imidazol

Country Status (29)

Country Link
US (1) US6265426B1 (es)
EP (1) EP1070708B1 (es)
JP (1) JP3628946B2 (es)
KR (1) KR100383776B1 (es)
CN (1) CN1148357C (es)
AR (1) AR024790A1 (es)
AT (1) ATE257827T1 (es)
AU (1) AU773463B2 (es)
BR (1) BR0003075A (es)
CA (1) CA2314009C (es)
CO (1) CO5190713A1 (es)
DE (1) DE60007697T2 (es)
DK (1) DK1070708T3 (es)
ES (1) ES2211420T3 (es)
HR (1) HRP20000482A2 (es)
HU (1) HUP0002792A3 (es)
ID (1) ID26599A (es)
IL (1) IL137328A0 (es)
MA (1) MA26747A1 (es)
MX (1) MXPA00007069A (es)
NO (1) NO20003723L (es)
NZ (1) NZ505766A (es)
PE (1) PE20010349A1 (es)
PL (1) PL341616A1 (es)
PT (1) PT1070708E (es)
SG (1) SG98422A1 (es)
TR (1) TR200002097A3 (es)
UY (1) UY26253A1 (es)
ZA (1) ZA200003680B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6610723B2 (en) 2001-01-29 2003-08-26 Hoffmann-La Roche Inc. Imidazole derivatives
CA2440284A1 (en) * 2001-03-08 2002-09-19 Emory University Ph-dependent nmda receptor antagonists
US6951875B2 (en) 2001-10-29 2005-10-04 Hoffmann-La Roche Inc. Conjugated aromatic compounds with a pyridine substituent
US7005432B2 (en) * 2002-05-16 2006-02-28 Hoffman-La Roche Inc. Substituted imidazol-pyridazine derivatives
WO2003105771A2 (en) 2002-06-17 2003-12-24 Merck & Co., Inc. 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
JP2006515276A (ja) * 2002-10-22 2006-05-25 オスコテック株式会社 骨粗鬆症の予防及び治療効果を有するフラン誘導体並びにこれを含む薬学的組成物
US7084145B2 (en) * 2002-10-25 2006-08-01 Pfizer Inc. Triazole compounds useful in therapy
CA2514363A1 (en) * 2003-02-12 2004-08-26 Transtech Pharma, Inc. Substituted azole derivatives as therapeutic agents
GB0303503D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
GB0315111D0 (en) 2003-06-27 2003-07-30 Cancer Rec Tech Ltd Substituted 5-membered ring compounds and their use
BRPI0417928A (pt) * 2003-12-22 2007-04-17 Merck & Co Inc composto, composição farmacêutica, métodos para o tratamento ou a prevenção de uma condição mediada pelo receptor de bradicinina b1, e de dor em um mamìfero, e, uso de um composto
ZA200605526B (en) * 2004-02-12 2007-11-28 Transtech Pharma Inc Substituted azole derivatives, compositions and methods of use
WO2007089857A2 (en) 2006-01-30 2007-08-09 Transtech Pharma, Inc. Substituted imidazole derivatives and their use as ptpase inhibitors
JO3019B1 (ar) * 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
KR101567608B1 (ko) 2007-02-08 2015-11-09 신타 파마슈티칼스 코프. 암과 같은 증식성 질환의 치료에 유용한 트라이아졸 화합물
LT2430921T (lt) 2007-04-03 2017-09-25 E. I. Du Pont De Nemours And Company Pakeistieji benzeno fungicidai
WO2008131148A1 (en) * 2007-04-19 2008-10-30 The Trustees Of The University Of Pennsylvania Diphenyl-heteroaryl derivatives and their use for binding and imaging amyloid plaques
US8420680B2 (en) 2007-06-29 2013-04-16 Emory University NMDA receptor antagonists for neuroprotection
JO2784B1 (en) * 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
CN101827836B (zh) 2007-10-18 2014-02-19 詹森药业有限公司 三取代的1,2,4-三唑化合物
MY152486A (en) 2008-03-19 2014-10-15 Janssen Pharmaceutica Nv Trisubstituted 1,2,4 - triazoles as nicotinic acetylcholine receptor modulators
EP2254580A1 (en) * 2008-03-27 2010-12-01 EVOTEC Neurosciences GmbH Methods for treating disorders using nmda nr2b-subtype selective antagonist
WO2009135944A1 (en) 2008-05-09 2009-11-12 Janssen Pharmaceutica Nv Trisubstituted pyrazoles as acetylcholine receptor modulators
RU2532394C1 (ru) * 2013-10-29 2014-11-10 Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон") ПРИМЕНЕНИЕ БРОМИДА 1-β-ФЕНИЛЭТИЛ)-4-АМИНО-1,2,4-ТРИАЗОЛИЯ (ГИПЕРТРИЛ) КАК АКТИВНОЙ ОСНОВЫ ЛЕКАРСТВЕННЫХ СРЕДСТВ ДЛЯ КОРРЕКЦИИ НАРУШЕНИЙ ФУНКЦИОНИРОВАНИЯ НИТРОКСИДЕРГИЧЕСКОЙ СИСТЕМЫ ОРГАНОВ-МИШЕНЕЙ ПРИ ГОМОЦИСТЕИНЕМИИ И ОСТРЫХ НАРУШЕНИЯХ МОЗГОВОГО КРОВООБРАЩЕНИЯ
EP3185684A1 (en) * 2014-08-29 2017-07-05 E. I. du Pont de Nemours and Company Herbicidal triazoles
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
US11912670B1 (en) 2023-10-25 2024-02-27 King Faisal University Ethyl 4-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)butanoate as an antimicrobial compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579352A (en) * 1977-05-06 1980-11-19 Lepetit Spa 3,5-disubstituted-1h-1,2,4-triazoles
DE19643037A1 (de) * 1996-10-18 1998-04-23 Boehringer Ingelheim Kg Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
PL337887A1 (en) * 1997-07-03 2000-09-11 Neurogen Corp Some diarylimidazole derivatives, novel class of specific npy ligands
IT1300055B1 (it) * 1998-04-17 2000-04-05 Boehringer Ingelheim Italia Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici
US7487474B2 (en) 2003-01-02 2009-02-03 Pdf Solutions, Inc. Designing an integrated circuit to improve yield using a variant design element

Also Published As

Publication number Publication date
ES2211420T3 (es) 2004-07-16
TR200002097A2 (tr) 2001-02-21
NZ505766A (en) 2002-03-28
PE20010349A1 (es) 2001-03-26
EP1070708A1 (en) 2001-01-24
PT1070708E (pt) 2004-05-31
ATE257827T1 (de) 2004-01-15
AU4865100A (en) 2001-01-25
DK1070708T3 (da) 2004-05-10
NO20003723L (no) 2001-01-22
BR0003075A (pt) 2001-03-13
CA2314009A1 (en) 2001-01-21
MA26747A1 (fr) 2004-12-20
TR200002097A3 (tr) 2001-02-21
US6265426B1 (en) 2001-07-24
ID26599A (id) 2001-01-25
NO20003723D0 (no) 2000-07-20
AU773463B2 (en) 2004-05-27
CN1281852A (zh) 2001-01-31
DE60007697T2 (de) 2004-12-09
KR100383776B1 (ko) 2003-05-12
KR20010049825A (ko) 2001-06-15
HU0002792D0 (en) 2000-09-28
IL137328A0 (en) 2001-07-24
DE60007697D1 (de) 2004-02-19
CN1148357C (zh) 2004-05-05
PL341616A1 (en) 2001-01-29
SG98422A1 (en) 2003-09-19
UY26253A1 (es) 2000-10-31
JP3628946B2 (ja) 2005-03-16
MXPA00007069A (es) 2002-04-24
HUP0002792A2 (hu) 2001-09-28
ZA200003680B (en) 2001-01-22
HRP20000482A2 (en) 2001-06-30
EP1070708B1 (en) 2004-01-14
CA2314009C (en) 2008-09-30
AR024790A1 (es) 2002-10-23
HUP0002792A3 (en) 2002-10-28
JP2001064263A (ja) 2001-03-13

Similar Documents

Publication Publication Date Title
CO5190713A1 (es) Derivados de triazol e imidazol
PE20001601A1 (es) Derivados de pirimidina como inhibidores de la sorbitol deshidrogenasa
NO170484C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater
JP2003519676A5 (es)
RU2005100053A (ru) Азуленовое производное и его соль
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
MX13455A (es) PROCEDIMIENTO PARA LA PREPARACION DE IMIDAZO-(2, 1-b) BENZOTIAZOLES.
JP2005526773A5 (es)
HK1054392A1 (en) Mehthod for the preparation of 5-cyanophthalide.
JP2001515025A5 (es)
JP2001519413A5 (es)
RU2004133388A (ru) Новые соли
NO20041761L (no) Nye hydroksyalkylindolokarbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
ECSP003582A (es) Derivados de imidazol y triazol
ES2172436B1 (es) Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
NO954538D0 (no) N-p-halobenzoylmetylderivater av 4-(p-fluorfenyl)-3-((3,4-metylendioksy)fenoksy)metyl)piperidin
NZ337243A (en) Use of aryl-cyclohexylamine derivatives as NMDA (N-methyl-D-aspartate) receptor subtype selective blockers against CNS disorders
RU2006106215A (ru) Производное бензиламина
AR038480A1 (es) Derivados de fenilglicina solubles en agua
DK200001669A (da) Nye carboxysubstituerede acycliske carboxamidderivater
PE20070718A1 (es) Macrolonas
TW427984B (en) N-hydroxyureas as antiinflammatory agents
ES515246A0 (es) &#34;procedimiento para la preparacion de nuevos 1-ariloxi-3-alquinilamino-2-propanoles&#34;.
ECSP982435A (es) 2,4- diamino pirimidina substituida
ES8802416A1 (es) Un procedimiento para la preparacion de derivados de dicloroanilina.

Legal Events

Date Code Title Description
FA Application withdrawn